High materiality7/10
Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
Why it may matterVerify against the original reporting
Bullish outlook based on higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target raised to $32 by Robert W. Baird for Regenxbio (RGNX).
- Target raised to $32 by Robert W. Baird; current price $8.91; potential upside.
Key facts
- 01
Target: $32
- 02
Posted price: $8.91
- 03
Analyst firm: Robert W. Baird
- 04
Analyst: Brian Skorney
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.